Biotech company Phylogica has announced plans to raise $26.8 million through a rights issue, fully underwritten by chairman and major shareholder Alan Tribe, with the proceeds used primarily to fund preclinicial studies for its leading drug molecule.
31/10/2019 - 13:24
Phylogica to raise $27m
31/10/2019 - 13:24
Related Data & Insights
-
-
Rank Company Revenue 87th PYC Therapeutics $15.8m 90th GreenHy2 $15.0m 91st K2fly $14.8m 93rd Advanced Braking Technology $14.7m 94th DTI Group $13.3m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
18 Mar 2024
O’Connor industrial lot to sell
14 Mar 2024
PYC taps investors for $75m
13 Jun 2023
Creasy buys $4.5m Nedlands site
30 May 2023
Commercial Content
Lions Eye Institute marks 40 years of eye care and medical research
18 May 2023
Collaboration key to shift science dial
11 May 2023
Perth biotech company raises $30m
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX